Source: Biomarker Insights. Unidade: FM
Subjects: ESTRÓGENOS, RECEPTORES HORMONAIS, NEOPLASIAS MAMÁRIAS
ABNT
GATTI, Pedro Henrique Fernandes et al. Downregulation of DNAJC12 expression predicts worse survival for ER-positive breast câncer patients. Biomarker Insights, v. 20, 2025Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/87337. Acesso em: 13 fev. 2026.APA
Gatti, P. H. F., Mangone, F. R. R., Pavanelli, A. C., Nonogaki, S., Osorio, C. A. B. de T., Capelozzi, V. L., & Nagai, M. A. (2025). Downregulation of DNAJC12 expression predicts worse survival for ER-positive breast câncer patients. Biomarker Insights, 20. doi:10.1177/11772719251323095NLM
Gatti PHF, Mangone FRR, Pavanelli AC, Nonogaki S, Osorio CAB de T, Capelozzi VL, Nagai MA. Downregulation of DNAJC12 expression predicts worse survival for ER-positive breast câncer patients [Internet]. Biomarker Insights. 2025 ; 20[citado 2026 fev. 13 ] Available from: https://observatorio.fm.usp.br/handle/OPI/87337Vancouver
Gatti PHF, Mangone FRR, Pavanelli AC, Nonogaki S, Osorio CAB de T, Capelozzi VL, Nagai MA. Downregulation of DNAJC12 expression predicts worse survival for ER-positive breast câncer patients [Internet]. Biomarker Insights. 2025 ; 20[citado 2026 fev. 13 ] Available from: https://observatorio.fm.usp.br/handle/OPI/87337
